Correlation Between Mineralys Therapeutics, and Revolution Medicines

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Revolution Medicines, you can compare the effects of market volatilities on Mineralys Therapeutics, and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Revolution Medicines.

Diversification Opportunities for Mineralys Therapeutics, and Revolution Medicines

0.68

Correlation Coefficient

Mineralys Therapeutics,  Revolution Medicines

Poor diversification

The 3 months correlation between Mineralys and Revolution is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Revolution Medicines go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Revolution Medicines

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Revolution Medicines. In addition to that, Mineralys Therapeutics, is 1.13 times more volatile than Revolution Medicines. It trades about -0.01 of its total potential returns per unit of risk. Revolution Medicines is currently generating about 0.04 per unit of volatility. If you would invest  2,650  in Revolution Medicines on November 20, 2024 and sell it today you would earn a total of  1,417  from holding Revolution Medicines or generate 53.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Revolution Medicines

Mineralys Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Revolution Medicines

Risk-Adjusted Performance

Very Weak

Over the last 90 days Revolution Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Mineralys Therapeutics, and Revolution Medicines

The main advantage of trading using opposite Mineralys Therapeutics, and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.

The idea behind Mineralys Therapeutics, Common and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.